首页> 外文期刊>Current opinion in chemical biology >Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles
【24h】

Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles

机译:工程化的结蛋白肽可作为诊断,治疗和药物传递载体

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Inhibitor cystine-knots, also known as knottins, are a structural family of ultra-stable peptides with diverse functions. Knottins and related backbone-cyclized peptides called cyclotides contain three disulfide bonds connected in a particular arrangement that endows these peptides with high thermal, proteolytic, and chemical stability. Knottins have gained interest as candidates for non-invasive molecular imaging and for drug development as they can possess the pharmacological properties of small molecules and the target affinity and selectively of protein biologics. Naturally occurring knottins are clinically approved for treating chronic pain and GI disorders. Combinatorial methods are being used to engineer knottins that can bind to other clinically relevant targets in cancer, and inflammatory and cardiac disease. This review details recent examples of engineered knottin peptides; their use as molecular imaging agents, therapeutics, and drug delivery vehicles; modifications that can be introduced to improve peptide folding and bioactivity; and future perspectives and challenges in the field.
机译:抑制剂胱氨酸结,也称为结蛋白,是具有多种功能的超稳定肽的结构家族。结蛋白和相关的称为环核苷酸的骨架环化肽包含以特定排列连接的三个二硫键,这些二硫键赋予这些肽以较高的热,蛋白水解和化学稳定性。结蛋白作为非侵入性分子成像和药物开发的候选物已引起人们的兴趣,因为它们可以具有小分子的药理特性以及靶标亲和力和蛋白质生物制剂的选择性。天然存在的结蛋白已被临床批准用于治疗慢性疼痛和胃肠道疾病。组合方法被用于工程化可与癌症,炎性和心脏病等临床上相关靶标结合的结蛋白。这篇综述详述了工程化的knottin肽的最新实例。它们用作分子显像剂,治疗剂和药物递送载体;可以引入以改善肽折叠和生物活性的修饰;以及该领域的未来前景和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号